Phosphagenics Limited

ASX:POH ISIN:AU000000POH7

Phosphagenics is a Melbourne-based, globally driven biotechnology company focused on the discovery of new and cost effective ways to enhance the bioavailability, activity, safety and delivery of proven pharmaceutical and nutraceutical products.

Phosphagenics' core technology is built around the science and application of phosphorylation, a process where the addition of a phosphate group has been found to enhance the bioavailability, activity and safety of existing pharmaceuticals and nutraceuticals, as well as to assist in the production of drug delivery platforms.

Phosphagenics' shares are listed on the Australian Stock Exchange (POH) and the London Stock Exchange's Alternative Investment Market (PSG). An ADR - Level 1 program was established in the U.S. with The Bank of New York Mellon (PPGNY) for U.S. investors to trade in Phosphagenics' stock on the 'over-the-counter' market. In July 2007, this was upgraded to the International OTCQX, a new premium market tier in the U.S. for international exchange-listed companies, operated by Pink Sheets, LLC. 
 
          

Voir en d'autres langues

Nouvelles

Rapport du marché australien en date du 7 février 2011 : Automotive Technology Group (ASX:ATJ) annonce le système de compresseur d’alimentation le plus efficace au monde

🕔2/7/2011 1:30:00 PM 11361

Le rapport du marché australien du 7 février 2011 inclut les titres suivants: Automotive Technology Group Limited (ASX:ATJ) annonce que le compresseur d'alimentation Sprintex(R) de la compagnie est le système de compresseur le plus efficace au monde; une étude sur le charbon met en lumière un potentiel d'exploitation de charbon thermique de catégorie d'exportation pour le projet Mmamantswe d'Aviva Corporation Limited (ASX:AVA) au Botswana; EnviroGold Limited (ASX:EVG) a renforcé son équipe de direction de manière significative en Amérique du Sud; Phosphagenics Limited (ASX:POH) a annoncé une collaboration pour développer un nouveau médicament contre le psoriasis aux Etats-Unis.

Lire l'article complet
###

84,329 COMPANY PROFILE VIEWS

  • This Page Viewed: (7 derniers jours: 7) (Last 30 Days: 42) (Since Published: 6657) 

Company Data

    Fax
  • 03 9605 5999 
  • Principal Sector
  • Health & Pharm 
  • Principal Industry
  • Biotechnology 
  • Homepage
  • www.phosphagenics.com

More News Results

  • 2024/02/20: General Security Deed*
  • 2024/02/20: Series Notice*
  • 2024/02/20: Notice of Creation of Trust*
  • 2024/02/20: Deed of Amendment*
  • 2024/02/20: Master Definition Schedule*
  • 2024/02/20: Master Security Trust Deed Amending Deed*
  • 2024/02/20: Master Trust Deed Amending Deed*
  • 2024/02/20: Information Memorandum*
  • 2024/02/20: Information Form and Checklist*
  • 2024/02/20: Appendix 1B*
*refer to company website